दवाओं की अंतःक्रिया
Alemtuzumab + Denosumab
गंभीरता: मध्यम
Alemtuzumab and Denosumab: moderate interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Alemtuzumab causes profound, prolonged lymphocyte depletion, and denosumab has been linked to serious infections. The combination may increase the risk of serious or opportunistic infection.
इस इंटरैक्शन का सरल भाषा में अर्थ
Alemtuzumab and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Alemtuzumab belongs to Miscellaneous; Denosumab belongs to Oncology.
ऐसा क्यों होता है
Additive immunosuppression from profound lymphocyte depletion by alemtuzumab and RANKL inhibition by denosumab.
क्या करें
Monitor closely for infection during and after alemtuzumab, and consider whether denosumab can be timed or deferred. Start prompt evaluation of any fever or infectious symptoms.
फार्मासिस्ट से क्या पूछें
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Alemtuzumab और Denosumab की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Denosumab के अन्य इंटरैक्शन
- Abatacept + Denosumab मध्यम
- Adalimumab + Denosumab मध्यम
- Alefacept + Denosumab मध्यम
- Anakinra + Denosumab मध्यम
- Azacitidine + Denosumab मध्यम
- Azathioprine + Denosumab मध्यम
Alemtuzumab के अन्य इंटरैक्शन
- Alemtuzumab + Fingolimod गंभीर
- Alemtuzumab + Ifosfamide गंभीर
- Alemtuzumab + Lomustine गंभीर
- Alemtuzumab + Ozanimod गंभीर
- Alemtuzumab + Siponimod गंभीर
- Alemtuzumab + Upadacitinib गंभीर
अक्सर पूछे जाने वाले प्रश्न
Can I take Alemtuzumab with Denosumab?
MediHelp rates the interaction as moderate. Alemtuzumab and Denosumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Alemtuzumab causes profound, prolonged lymphocyte depletion, and denosumab has been linked to serious infections. The combination may increase the risk of serious or opportunistic infection.
How serious is the interaction between Alemtuzumab and Denosumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor closely for infection during and after alemtuzumab, and consider whether denosumab can be timed or deferred. Start prompt evaluation of any fever or infectious symptoms.
What other medicines interact with Denosumab?
MediHelp also lists interactions of Denosumab with, for example, Abatacept, Adalimumab, Alefacept. The full list is on the Denosumab page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
